Chugai Pharmaceutical at PEGS Europe 2026
Nov 16–19, 2026 Lisbon, Portugal ~1.5k attendees Website
Chugai Pharmaceutical brings 3 presentations to PEGS Europe 2026 in Lisbon. Its program combines conditional activation with Fc engineering and looks at how to spot mis-paired variants across bispecific antibody formats. Another strand uses molecular dynamics to explain how formulation changes the thermal behaviour of antibodies.
| Organization | PEGS Europe 2026 Attendance |
|---|---|
Chugai Pharmaceutical Tokyo, Japan | |
Japanese pharmaceutical company in the Roche group, known for antibody engineering technologies such as recycling and bispecific antibodies. | Talk Wed Nov 18 8:30am–9:00am Talk Wed Nov 18 8:30am–9:00am Talk Thu Nov 19 2:35pm–3:05pm |
Instantly find 20 buyers from Chugai Pharmaceutical
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by PEGS Europe or its organizers. Submit a correction